Digital Genome Market to grow at 9.5% CAGR from 2016 to 2024: Fractovia.org The global industry report "Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments), By Application (Microbiology [Biological, Clinical, Industrial], Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain, Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024" by Global Market Insights, Inc. says Digital Genome Market size is set to exceed USD 45 billion by 2024. Digital genome market value will ascend rapidly propelled by the high speed and precision of human genome sequencing. Government and private organizations have subsequently increased their funding to enhance the development of novel sequencing methodologies. This factor is expected to considerably stimulate the industry trends over the span of the next few years.
Industry insights of digital genome industry based on the application, product, end-use, and region are mentioned below: Academic research institute end use segment will register high growth rate over the coming seven years, primarily driven by the huge economical backing by investors for improvised services, instruments, and technological innovations. Other end use segments in the digital genome market are bio-pharmaceutical companies, hospitals, and diagnostics & forensic labs. Research & development, microbiology, transportation, reproductive & genetic, and livestock & agriculture are the main application sectors of digital genome industry. Microbiology application accounted for more than 22% of the overall market share in 2015 and will collect a revenue of more than USD 10 billion by 2024, owing to the growing demand for microbes across the biological, industrial, and clinical sectors.
1|Page